How does comorbidity affect cost of health care in patients with irritable bowel syndrome? A cohort study in general practice
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Background: Irritable bowel syndrome (IBS) is associated with other disorders (comorbidity), reduced quality of life and increased use of health resources. We aimed to explore the impact of comorbidity on cost of health care in patients with IBS in general practice. Methods: In this cohort study 208 consecutive patients with IBS (Rome II) were recruited. Sociodemographic data, IBS symptoms, and comorbidity (somatic symptoms, organic diseases and psychiatric disorders) were assessed at baseline. Based on a follow up interview after 6-9 months and use of medical records, IBS and non-IBS related health resource use were measured as consultations, hospitalisations, use of medications and alternative health care products and sick leave days. Costs were calculated by national tariffs and reported in Norwegian Kroner (NOK, 1 EURO equals 8 NOK). Multivariate analyses were performed to identify predictors of costs. Results: A total of 164 patients (mean age 52 years, 69% female, median duration of IBS 17 years) were available at follow up, 143 patients (88%) had consulted their GP of whom 31 (19%) had consulted for IBS. Mean number of sick- leave days for IBS and comorbidity were 1.7 and 16.3 respectively (p < 0.01), costs related to IBS and comorbidity were 954 NOK and 14854 NOK respectively (p < 0.001). Age, organic diseases and somatic symptoms, but not IBS severity, were significant predictors for total costs. Conclusion: Costs for health resource use among patients with IBS in general practice were largely explained by comorbidity, which generated ten times the costs for IBS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Functional bowel disorders and functional abdominal pain
Thompson, W. G., Longstreth, G. F., Drossman, D. A., Heaton, K. W., Irvine, E. J., & Müller-Lissner, S. A. (1999) · Gut · doi:10.1136/gut.45.2008.ii43 · Cited by 2,440
Drossman, D. A., Li, Z., Andruzzi, E., Temple, R. D., Talley, N. J., Grant Thompson, W., Whitehead, W. E., Janssens, J., Funch-Jensen, P., Corazziari, E., et al. (1993) · Digestive Diseases and Sciences · doi:10.1007/bf01303162 · Cited by 2,198 · cited 1×
“Irritable bowel syndrome (IBS) is a functional gastrointestinal disorder (FGID) affecting 8%-20% of the adult population in the western countries [1-3].”
BackgroundPincus, T., Burton, A. K., Vogel, S., & Field, A. P. (2002) · Spine · doi:10.1097/00007632-200203010-00017 · Cited by 1,633 · cited 1×
“Accordingly a systematic review of patients with chronic low back pain found an association between comorbid mood disorders and health care costs [19].”
BackgroundStrand, B. H., Dalgard, O. S., Tambs, K., & Rognerud, M. (2003) · Nordic Journal of Psychiatry · doi:10.1080/08039480310000932 · Cited by 1,304 · cited 1×
“Health anxiety was measured by Whitley index (score range 14-60) and neuroticism by EPQ-10 (score range 0-10) [13-15].”
MethodWhitehead, W. E., Palsson, O., & Jones, K. R. (2002) · Gastroenterology · doi:10.1053/gast.2002.32392 · Cited by 1,116 · cited 2×
“Consideration of comorbidity as an explanatory factor for use of health resources is warranted since patients with IBS frequently report other somatic and psychiatric disorders [9,10].”
BackgroundFord, A. C., Talley, N. J., Schoenfeld, P. S., Quigley, E. M. M., & Moayyedi, P. (2009) · Gut · doi:10.1136/gut.2008.163162 · Cited by 582
A scoring system for subjective health complaints (SHC)
Eriksen, H. R., Ihlebæk, C., & Ursin, H. (1999) · Scandinavian Journal of Public Health · doi:10.1177/14034948990270010401 · Cited by 415
Speckens, A. E. M., Spinhoven, P., Sloekers, P. P. A., Bolk, J. H., & van Hemert, A. M. (1996) · Journal of Psychosomatic Research · doi:10.1016/0022-3999(95)00561-7 · Cited by 303 · cited 1×
“Health anxiety was measured by Whitley index (score range 14-60) and neuroticism by EPQ-10 (score range 0-10) [13-15].”
MethodThe relationship between somatisation and outcome in patients with severe irritable bowel syndrome
Creed, F., Tomenson, B., Guthrie, E., Ratcliffe, J., Fernandes, L., Read, N., Palmer, S., & Thompson, D. G. (2008) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2008.02.016 · Cited by 71
Cited by
Review article: the economic impact of the irritable bowel syndrome
Canavan, C., West, J., & Card, T. (2014) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12938 · Cited by 458
“times greater [NOK 14 856 (€1857)].(56) National annual projections for the cost to a country of treating patients with IBS range from £45.”
BackgroundIrritable bowel syndrome: A clinical review
Soares, R. L. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i34.12144 · Cited by 266
Implications of comorbidity for primary care costs in the UK: a retrospective observational study
Brilleman, S. L., Purdy, S., Salisbury, C., Windmeijer, F., Gravelle, H., & Hollinghurst, S. (2013) · British Journal of General Practice · doi:10.3399/bjgp13x665242 · Cited by 87
Economic burden of irritable bowel syndrome in China
Zhang, F., Xiang, W., Li, C.-Y., & Li, S.-C. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i47.10450 · Cited by 94
Multiple somatic symptoms predict impaired health status in functional somatic syndromes
Creed, F. H., Tomenson, B., Chew-Graham, C., Macfarlane, G. J., Davies, I., Jackson, J., Littlewood, A., & McBeth, J. (2013) · International Journal of Behavioral Medicine · doi:10.1007/s12529-012-9257-y · Cited by 63
“There is evidence from both clinic-based and populationbased studies that the health status of patients with FSS is most impaired in patients with multiple somatic symptoms [25, 30–34].”
Background
Metadata
- Authors
- Johansson, P. A., Farup, P. G., Bracco, A., & Vandvik, P. O.
- Venue
- BMC Gastroenterology
- Published
- 2010-03-17
- Volume
- 10
- Issue
- 1
- Pages
- 31-31
- ISSN
- 1471-230X (ISSN-L)
- OpenAlex
- W2161349124
- Cited by
- 60
- References
- 9
- FWCI
- 5.79
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: How does comorbidity affect cost of health care in patients with irritable bowel syndrome? A cohort study in general practice. https://app.cochat.ai/papers/10.1186/1471-230x-10-31
- The paper
- Johansson, P. A., Farup, P. G., Bracco, A., & Vandvik, P. O. (2010). How does comorbidity affect cost of health care in patients with irritable bowel syndrome? A cohort study in general practice. BMC Gastroenterology. https://doi.org/10.1186/1471-230x-10-31
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.